Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCornerLoc

About this trial

This is a multi-center, consecutive enrollment registry study to evaluate patient satisfaction post SI Fusion with the TransLoc 3D SI Fusion System.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 year or older

Confirmed Implant of the Transloc 3D Fusion System

Did not have Transloc device removed or another manufacturer device implanted post Transloc

Does not have other manufacturer's titanium or metal implant

Disqualifiers

Patient is younger than 18 years

Patient is unable to sign the Informed Consent

Implant of other manufacturer's titanium or alternative metal implant

Revision with another manufacturer's implant

Trial population

Patients who have already received the TransLoc 3D System \> 1 year postoperatively \< 18 months, at the time of consent.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • TransLoc 3D SI Joint Fusion System

    Device

    Satisfaction survey will be administered to collect real world evidence on patients that previously received the TransLoc 3D System commercially.

Treatment groups

120 Participants
are divided into 1 treatment group
Group A: Implanted TransLoc 3D SIJ Fusion Patients1 intervention

Trial outcomes

Primary outcomes

1

Patient Satisfaction Survey

Patient satisfaction survey administered greater than 1 year post-op: satisfaction, functional improvement, and disability as it relates to their SI joint

Time frame
Prospective 12 to 18 months post surgery

Secondary outcomes

1

Visual Analogue Scale (VAS) of pain

Retrospective analysis of VAS pre and post surgery, if available

Time frame
Baseline up to 1 year post surgery
2

Oswestry Disability Index (ODI)

Retrospective analysis of ODI pre and post surgery, if available

Time frame
Baseline up to 1 year post surgery
3

SAEs

Retrospective capture of Serious Adverse Events (SAEs) from the time of SI Fusion up to 90 days post operatively that required re-operation or in-patient hospitalization.

Time frame
Time of surgery up to 90 days post surgery
4

CT Scan Second Read (Radiological Overread)

CT scan for placement and fusion

Time frame
12 to 18 months post fusion surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.